[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. notice of proposed sale under Rule 144 reports an intended sale of 50,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $6,441,500.00 based on the filing. The shares were acquired as founders shares on 11/13/2017. The filer also discloses multiple recent Rule 10b5-1 and direct sales totaling 341,323 shares across dates from 08/27/2025 to 10/07/2025 with combined gross proceeds shown per sale (examples: $10,952,733.12 on 09/30/2025, $8,130,425.59 on 10/07/2025). The filing includes the required representation that the seller is not aware of undisclosed material adverse information and notes reliance on Rule 10b5-1 where applicable.

Positive

• Disclosure compliance is observed: Rule 144 notice filed with sale details and prior 10b5-1 sales listed
• Sizable proceeds from recent sales (examples include $10,952,733.12 and $8,130,425.59) indicating successful execution of planned dispositions

Negative

• Insider selling concentration of several hundred thousand shares within weeks could be viewed unfavorably by some investors
• Filing lacks contextual detail on whether the planned sale will be part of an ongoing program or a one-off transaction

Insights

Securities Compliance Analyst

TL;DR: Transaction appears procedural and consistent with Rule 144 and 10b5-1 disclosures.

The notice documents a planned Rule 144 sale of 50,000 common shares and lists prior 10b5-1 sales and direct sales totaling several hundred thousand shares between 08/27/2025 and 10/07/2025

This pattern suggests ongoing, pre-arranged dispositions rather than one-off insider trades; compliance hinges on accurate aggregation of sales, proper filing timing, and the seller's certification of no undisclosed material adverse information. Watch for any subsequent filings that update quantities, cancellation of the 10b5-1 plan, or disclosure of material events within typical post-sale windows.

Equity Markets Analyst

TL;DR: The disclosed sales represent modest supply relative to outstanding shares but generate meaningful cash flows.

The filing shows the proposed sale of 50,000 shares against 370,470,348 shares outstanding, implying a small dilution/float impact on an absolute basis. Recent gross proceeds per sale range from roughly $3.1M to $10.95M, indicating execution at varying prices across dates.

Investors may note the cumulative selling volume over the past six weeks exceeds 300k shares; monitor share-price reaction around announced sale dates and any company disclosures that could affect liquidity or perceived insider sentiment over the next few trading sessions.

10/08/2025 - 04:20 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	6441500.00	370470348	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/07/2025	61810	8130425.59
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/30/2025	78548	10952733.12
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/24/2025	32455	4223680.72
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/24/2025	50000	6506980.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	32455	3840276.82
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	50000	5916310.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	32455	3104307.77
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CRWV report?

It reports a proposed Rule 144 sale of 50,000 common shares via Morgan Stanley Smith Barney LLC with aggregate market value $6,441,500.00 and lists recent 10b5-1 sales.

When were the shares to be sold originally acquired?

The shares were acquired as Founders Shares on 11/13/2017 according to the filing.

How many shares are outstanding for CoreWeave (CRWV) per the filing?

The filing reports 370,470,348 shares outstanding.

What recent insider sales does the filing disclose?

The filing lists multiple sales from 08/27/2025 to 10/07/2025, including transactions of 61,810, 78,548, 32,455, and 50,000 shares with gross proceeds shown per trade.

Does the filer assert any material non-public information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.